Over the past five trading sessions, select smallcap stocks posted gains of up to 27%. Fermenta Biotech led with a 26% rise, followed by Stallion India Fluorochemicals and Rolex Rings. Sectors such as niche pharma, specialty chemicals, auto components, media, IT, and infrastructure witnessed renewed investor interest. The rally highlights heightened volatility, speculative activity, and rapid price discovery in smaller companies.Read More
Silver futures surged past Rs 2,00,000 on MCX, hitting lifetime highs amid strong industrial demand, supply deficits, and supportive monetary conditions. While experts remain bullish on the long-term outlook, some caution that the metal is technically overstretched, making near-term corrections possible.Read More
Motilal Oswal’s 30th Wealth Creation Study shows record Rs 148 trillion wealth creation during 2020–2025, led by Bharti Airtel, ICICI Bank and SBI. BSE emerged fastest, HAL most consistent, while financials and PSUs drove returns, reinforcing the value of long-term, fundamentals-led investing.Read More
Corona Remedies and Wakefit Innovations are set to list amid divergent grey market signals. Corona Remedies commands strong listing expectations backed by robust subscriptions and profitability, while Wakefit’s muted GMP reflects cautious sentiment towards consumer-facing growth businesses, highlighting current investor preference for earnings visibility and consistency.Read More
Analyst forecasts identify 10 Nifty500 stocks with upside potential ranging from 35% to nearly 50% over the next year. Highlights include Cohance Lifesciences, Brigade Enterprises, Kaynes Technology, and Balrampur Chini. Consensus ratings and sequential quarterly profit growth provide data-backed guidance for investors seeking high-potential, long-term market opportunities.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
